Pacira BioSciences Files 8-K on Exit Costs
Ticker: PCRX · Form: 8-K · Filed: Jul 10, 2025 · CIK: 1396814
| Field | Detail |
|---|---|
| Company | Pacira Biosciences, Inc. (PCRX) |
| Form Type | 8-K |
| Filed Date | Jul 10, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: exit-costs, disposal-activities, regulation-fd
Related Tickers: PCRX
TL;DR
Pacira BioSciences filed an 8-K on July 9, 2025, detailing exit/disposal costs.
AI Summary
On July 9, 2025, Pacira BioSciences, Inc. filed an 8-K report detailing cost associated with exit or disposal activities. The filing also included Regulation FD disclosures and financial statements and exhibits. The company, formerly known as Pacira Pharmaceuticals, Inc., is incorporated in Delaware.
Why It Matters
This filing indicates potential restructuring or divestiture activities within Pacira BioSciences, which could impact its future operational focus and financial performance.
Risk Assessment
Risk Level: medium — Filings related to exit or disposal activities can signal significant strategic shifts or financial challenges for a company.
Key Players & Entities
- Pacira BioSciences, Inc. (company) — Registrant
- July 9, 2025 (date) — Date of Earliest Event Reported
- Delaware (jurisdiction) — State of Incorporation
- Pacira Pharmaceuticals, Inc. (company) — Former Company Name
- 2000 Sierra Point Parkway, Suite 900 Brisbane, California 94005 (address) — Principal Executive Offices
FAQ
What specific activities are associated with the 'cost associated with exit or disposal activities' mentioned in the filing?
The filing does not specify the exact nature of the exit or disposal activities, but it is reported under Item 2.01 and Item 9.01.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
Regulation FD (Fair Disclosure) ensures that material information is broadly disseminated to the public, preventing selective disclosure to analysts or institutional investors.
When was Pacira BioSciences, Inc. incorporated, and in which state?
Pacira BioSciences, Inc. was incorporated in Delaware.
What are the former names of Pacira BioSciences, Inc. and when did these name changes occur?
The company was formerly known as Pacira Pharmaceuticals, Inc. (name change date not specified in this excerpt), PACIRA INC (name change date 20080318), and Blue Acquisition Corp (name change date 20070418).
What is the principal executive office address for Pacira BioSciences, Inc.?
The principal executive office is located at 2000 Sierra Point Parkway, Suite 900, Brisbane, California 94005.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 10, 2025 regarding Pacira BioSciences, Inc. (PCRX).